A detailed history of United Capital Financial Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 65,450 shares of AMGN stock, worth $18.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
65,450
Previous 65,947 0.75%
Holding current value
$18.8 Million
Previous $20.6 Million 2.34%
% of portfolio
0.11%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $153,761 - $167,677
-497 Reduced 0.75%
65,450 $21.1 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $5.85 Million - $7.11 Million
22,271 Added 50.99%
65,947 $20.6 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $2.97 Million - $3.59 Million
-11,060 Reduced 20.21%
43,676 $12.4 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $11.9 Million - $13.5 Million
-46,714 Reduced 46.05%
54,736 $15.8 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $805,943 - $1 Million
-3,686 Reduced 3.51%
101,450 $27.3 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $1.62 Million - $1.92 Million
-7,578 Reduced 6.72%
105,136 $23.3 Million
Q1 2023

Aug 14, 2023

BUY
$225.79 - $275.2 $1.22 Million - $1.49 Million
5,420 Added 5.16%
110,556 $26.7 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $4.61 Million - $5.62 Million
-20,431 Reduced 15.34%
112,714 $27.2 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $1.21 Million - $1.53 Million
-5,267 Reduced 3.81%
133,145 $35 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $2.28 Million - $2.57 Million
10,146 Added 7.91%
138,412 $31.2 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $1.19 Million - $1.32 Million
-5,150 Reduced 3.86%
128,266 $31.2 Million
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $216,419 - $239,416
987 Added 0.75%
133,416 $32.3 Million
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $326,759 - $373,946
1,643 Added 1.26%
132,429 $29.8 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $159,202 - $186,525
750 Added 0.58%
130,786 $27.8 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $1.41 Million - $1.56 Million
6,036 Added 4.87%
130,036 $31.7 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $2.85 Million - $3.32 Million
12,846 Added 11.56%
124,000 $30.9 Million
Q4 2020

Feb 17, 2021

BUY
$216.38 - $257.67 $1.07 Million - $1.27 Million
4,924 Added 4.64%
111,154 $25.6 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $805,553 - $895,841
3,433 Added 3.34%
106,230 $27 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $23.5 Million - $28.8 Million
-118,609 Reduced 53.57%
102,797 $24.2 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $64,330 - $85,320
-353 Reduced 0.16%
221,406 $43.9 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $2.97 Million - $3.81 Million
15,671 Added 7.6%
221,759 $53.5 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $5.26 Million - $6.3 Million
-30,211 Reduced 12.79%
206,088 $39.9 Million
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $575,281 - $674,359
-3,451 Reduced 1.44%
236,299 $43.5 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $1.34 Million - $1.51 Million
7,419 Added 3.19%
239,750 $45.5 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $7.94 Million - $9.27 Million
-44,528 Reduced 16.08%
232,331 $45.2 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $1.04 Million - $1.17 Million
5,618 Added 2.07%
276,859 $57.4 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $2.16 Million - $2.43 Million
13,020 Added 5.04%
271,241 $50.1 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $16.5 Million - $19.3 Million
97,669 Added 60.83%
258,221 $44 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $397,838 - $444,506
2,357 Added 1.49%
160,552 $28.1 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $20.8 Million - $23.8 Million
124,552 Added 370.22%
158,195 $29.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
33,643
33,643 $5.79 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.